SCHEDULE 13G/A 0002000324-25-000367 0001746382 XXXXXXXX LIVE 1 Common Stock, $0.001 par value 03/31/2025 0001342958 DIGITAL ALLY, INC. 25382T200 6366 College Blvd. Overland Park KS 66211 Rule 13d-1(c) Altium Capital Management LLC DE 0 40000000.00 0 40000000.00 40000000.00 N 4.99 IA See Item 4 for a description of the information reported in rows (6), (8), (9) and (11). Altium Healthcare Long Short Onshore Fund LP DE 0 40000000.00 0 40000000.00 40000000.00 N 4.99 PN See Item 4 for a description of the information reported in rows (6), (8), (9) and (11). Altium Healthcare Long Short GP LLC DE 0 40000000.00 0 40000000.00 40000000.00 N 4.99 OO See Item 4 for a description of the information reported in rows (6), (8), (9) and (11). DIGITAL ALLY, INC. 6366 COLLEGE BLVD., OVERLAND PARK, KS, 66211 This statement is jointly filed by and on behalf of each of Altium Healthcare Long Short Onshore Fund LP (the "Fund"), Altium Capital Management LLC, and Altium Healthcare Long Short GP LLC. The Fund is the record and direct beneficial owner of the securities covered by this statement. Altium Capital Management LLC is the investment adviser of, and may be deemed to beneficially own securities, owned by the Fund. Altium Healthcare Long Short GP LLC is the general partner of, and may be deemed to beneficially own securities, owned by the Fund. Each Reporting Person declares that neither the filing of this statement nor anything herein shall be construed as an admission that such person is, for the purposes of Section 13(d) or 13(g) of the Act or any other purpose, the beneficial owner of any securities covered by this statement. Each of the Reporting Persons may be deemed to be a member of a group with respect to the Issuer or securities of the Issuer for the purposes of Section 13(d) or 13(g) of the Act. Each of the reporting persons declares that neither the filing of this statement nor anything herein shall be construed as an admission that such person is, for the purposes of Section 13(d) or 13(g) of the Act or any other purpose, (i) acting (or has agreed or is agreeing to act together with any other person) as a partnership, limited partnership, syndicate, or other group for the purpose of acquiring, holding, or disposing of securities of the Issuer or otherwise with respect to the Issuer or any securities of the Issuer or (ii) a member of any group with respect to the Issuer or any securities of the Issuer. The address of the principal business office of each of the reporting persons is 152 West 57th Street, FL 20, New York, NY 10019. See Item 4 on the cover page(s) hereto. Y Pursuant to the terms of the securities purchase agreement entered into between the Fund and the Issuer, the Fund purchased Series A Warrants and Series B Warrants (the "Warrants"). The Series A Warrants and Series B Warrants are each subject to a 4.99% blocker (the "Warrant Blocker") and as a result the Reporting Persons cannot exercise the Warrants to the extent the Reporting Persons would beneficially own, after any such conversion or exercise, more than 4.99% outstanding shares of Common Stock. However the securities reported in rows (6), (8) and (9) show the number of shares of Common Stock that would be issuable upon full conversion and exercise of such Warrants and does not give effect to the Warrant Blockers. Therefore, the actual number of shares of Common Stock beneficially owned by each such Reporting Person, after giving effect to such Warrant Blockers, is less than the number of securities reported in rows (6), (8) and (9).The securities reported in rows (6), (8) and (9) of each Cover Page are inclusive of the following: 20,000,000 shares of Common Stock issuable up conversion of Series A Warrants and 20,000,000 shares of Common Stock issuable up conversion of Series B Warrants. The percentage in row (11) is based on 115,601,371 shares of Common Stock outstanding as of May 2, 2025, as set forth in the Issuer's Form 10-K filed with the Securities and Exchange Commission ("SEC") on May 2, 2025. 4.99 See responses to Item 5 on each cover page. See responses to Item 6 on each cover page. See responses to Item 7 on each cover page. See responses to Item 8 on each cover page. N Y Y Y Y Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11. Altium Capital Management LLC Jacob Gottlieb 05/15/2025 Altium Healthcare Long Short Onshore Fund LP Jacob Gottlieb 05/15/2025 Altium Healthcare Long Short GP LLC Jacob Gottlieb 05/15/2025